Summary

The cell isolation market is expected to reach USD 7.97 billion in 2031 from USD 4.39 billion in 2026, at a CAGR of 12.7% during the forecast period. The market is primarily driven by the expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, and increasing use of automated and closed isolation systems. Technologies such as centrifugation-based isolation, magnetic-activated cell separation, fluorescence-activated cell sorting, microfluidic isolation, and filtration-based separation enable the enrichment and purification of specific cell populations, including immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells. These technologies support applications across drug discovery, immunology research, cancer biology, regenerative medicine, biomarker discovery, and clinical research. In addition, the growing demand for GMP-grade cell isolation products is driving adoption of validated kits, magnetic beads, single-use consumables, and closed-system platforms across clinical and manufacturing workflows. However, market growth continues to be challenged by the high cost of instruments and consumables, loss of cell viability and recovery during isolation, and difficulties in scaling research workflows to GMP manufacturing while balancing purity, yield, viability, and cost.

https://mnmimg.marketsandmarkets.com/Images/cell-isolation-market-img-overview.webp

“The consumables segment is expected to grow at the highest CAGR during the forecast period”
The consumables segment is projected to grow at the highest CAGR in the cell isolation market, driven by the recurring use of magnetic beads, antibody-based isolation kits, density gradient media, buffers, cell strainers, columns, and single-use kits across research and clinical workflows. These products are widely used for immune cell isolation, stem cell enrichment, isolation of circulating tumor cells, primary cell separation, and sample preparation for downstream analysis. The growing use of cell isolation in cell and gene therapy development, single-cell analysis, immunology research, and cancer biology is increasing demand for high-purity, validated, and application-specific consumables.
“Human cells segment holds the largest share of the market”
The human cells segment accounts for the largest share of the cell isolation market, driven by the increasing use of human-derived immune cells, stem cells, circulating tumor cells, leukocytes, and primary cells in drug discovery, translational research, regenerative medicine, and clinical applications. Human cell isolation plays a critical role in immune profiling, biomarker discovery, cancer research, personalized medicine, and cell and gene therapy workflows. The growing demand for biologically relevant human cell models, along with the rising adoption of single-cell analysis and GMP-compatible cell processing, continues to strengthen this segment's position.
“The US is expected to grow at the highest CAGR during the forecast period”
The US is expected to grow at the highest CAGR in the cell isolation market due to its strong presence of leading life science companies, advanced biomedical research infrastructure, and high adoption of cell separation technologies across research and clinical settings. The rising use of cell isolation in cell and gene therapy development, immuno-oncology, stem cell research, single-cell analysis, and biomarker discovery is a key factor driving market growth. Technologies such as magnetic-activated cell separation, fluorescence-activated cell sorting, centrifugation-based isolation, and automated closed-system platforms are widely used across pharmaceutical companies, biotechnology firms, academic institutes, and clinical laboratories, further supporting demand.
The primary interviews conducted for this report can be categorized as follows:

? By Respondent: Supply Side ? 70% and Demand Side? 30%
? By Designation: Managers ? 45%, CXOs and Directors ? 30%, and Executives ? 25%
? By Region: North America ? 40%, Europe ? 25%, Asia Pacific ? 25%, Latin America ? 5%, the Middle East & Africa ? 5%
Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), Corning Incorporated (US), Lonza (Switzerland), Bio-Techne (US), Terumo Corporation (Japan), Miltenyi Biotec (Germany), Takara Bio Inc. (Japan), GenScript (US), Sony Group Corporation (Japan), Alfa Laval (Sweden), Promega Corporation (US), Cell Signaling Technology, Inc. (US), MiCareo Inc. (Taiwan), Applied Cells, Inc. (US), STEMCELL Technologies (Canada), Creative Bioarray (US), Proteintech Group, Inc. (US), MagBio Genomics, Inc. (US), Akadeum Life Sciences (US), pluriSelect Life Science UG (haftungsbeschr?nkt) & Co. KG (Germany), and Invent Biotechnologies, Inc. (US) are some of the key companies offering cell isolation products.

Research Coverage
This research report categorizes the cell isolation market by product (consumables [reagents & kits {cell isolation reagents & kits, tissue dissociation reagents & kits, other reagents & kits}, media and sera, beads {magnetic beads, fluorescent beads}, and disposables] and instruments [centrifuges, cell sorters, magnetic-activated cell separator systems, filtration systems, and other instruments]), cell type (human cells [differentiated cells, stem cells] and animal cells), cell source (blood & blood-derived samples, adipose tissue, bone marrow, cord blood/embryonic stem cells, and other cell sources), technique (centrifugation-based cell isolation, surface marker-based cell isolation, filtration-based cell isolation, and microfluidics & label-free cell isolation), application (research applications [biomolecule isolation, cancer research, stem cell research, regenerative medicine, and other research applications], drug discovery and development, in vitro diagnostics, CGT manufacturing), end user (pharmaceutical & biotechnology companies, academic & research institutes, biopharmaceutical companies, hospitals & diagnostic laboratories, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
The report’s scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the cell isolation market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, key strategies, new product launches, acquisitions, and recent developments in the cell isolation market. This report also includes a competitive analysis of emerging startups in the cell isolation industry ecosystem.
Key Benefits of Buying the Report
The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
? Analysis of key drivers (expansion of cell and gene therapy workflows, rising demand for immune cell isolation, growing adoption of single-cell analysis, shift toward automated and closed isolation systems), restraints (high cost of instruments and consumables, loss of cell viability and recovery during isolation), opportunities (growing demand for GMP-grade cell isolation products, adoption of microfluidic and label-free isolation technologies), and challenges (scaling research workflows to GMP manufacturing, balancing purity, yield, viability, and cost) influencing the market growth
? Product Development/Innovation: Detailed insights into newly launched products and innovations in the cell isolation market
? Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
? Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players, Danaher (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), BD (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Revvity (US), and Corning Incorporated (US), among others, for the cell isolation market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 46
1.3.1 MARKET SEGMENTATION & REGIONS COVERED 47
1.3.2 INCLUSIONS & EXCLUSIONS 48
1.3.3 YEARS CONSIDERED 49
1.3.4 CURRENCY CONSIDERED 49
1.4 STAKEHOLDERS 49
1.5 SUMMARY OF CHANGES 50
2 EXECUTIVE SUMMARY 51
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 51
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 52
2.3 DISRUPTIVE TRENDS IN CELL ISOLATION MARKET 53
2.4 HIGH-GROWTH SEGMENTS 54
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 55
3 PREMIUM INSIGHTS 56
3.1 CELL ISOLATION MARKET OVERVIEW 56
3.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY 57
3.3 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 58
3.4 CELL ISOLATION MARKET SHARE, BY PRODUCT, 2026 VS. 2031 (%) 58
4 MARKET OVERVIEW 59
4.1 INTRODUCTION 59
4.2 MARKET DYNAMICS 60
4.2.1 DRIVERS 61
4.2.1.1 Expansion of cell and gene therapy workflows 61
4.2.1.2 Rising demand for immune cell isolation 61
4.2.1.3 Growing adoption of single-cell analysis 62
4.2.1.4 Shift toward automated and closed isolation systems 62
4.2.2 RESTRAINTS 62
4.2.2.1 High cost of instruments and consumables 62
4.2.2.2 Loss of cell viability and recovery during isolation 63
4.2.3 OPPORTUNITIES 63
4.2.3.1 Growing demand for GMP-grade cell isolation products 63
4.2.3.2 Adoption of microfluidic and label-free isolation technologies 64
?
4.2.4 CHALLENGES 64
4.2.4.1 Scaling research workflows to GMP manufacturing 64
4.2.4.2 Balancing purity, yield, viability, and cost 65
4.3 UNMET NEEDS & WHITE SPACES 65
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 66
4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 66
5 INDUSTRY TRENDS 68
5.1 PORTER’S FIVE FORCES ANALYSIS 68
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 69
5.1.2 BARGAINING POWER OF SUPPLIERS 69
5.1.3 BARGAINING POWER OF BUYERS 70
5.1.4 THREAT OF SUBSTITUTES 70
5.1.5 THREAT OF NEW ENTRANTS 70
5.2 MACROECONOMIC OUTLOOK 70
5.2.1 INTRODUCTION 70
5.2.2 GDP TRENDS & FORECAST 71
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 71
5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY 71
5.3 VALUE CHAIN ANALYSIS 72
5.4 ECOSYSTEM ANALYSIS 73
5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 75
5.5 PRICING ANALYSIS 75
5.5.1 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023?2025 76
5.5.2 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023?2025 77
5.5.3 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023?2025 78
5.5.4 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023?2025 78
5.6 TRADE ANALYSIS 79
5.6.1 IMPORT SCENARIO (HS CODE 3822.00) 80
5.6.2 EXPORT SCENARIO (HS CODE 3822.00) 80
5.7 KEY CONFERENCES & EVENTS, 2026?2027 81
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 82
5.9 INVESTMENT & FUNDING SCENARIO 82
5.10 CASE STUDY ANALYSIS 84
5.10.1 MICROFLUIDIC CELL SORTING IMPROVES CAR-T STARTING MATERIAL QUALITY 84
5.10.2 CLOSED-SYSTEM CELL ENRICHMENT SUPPORTS NK CELL MANUFACTURING 84
5.10.3 MICROFLUIDIC ISOLATION ENHANCES CTC RECOVERY IN PANCREATIC CANCER 84
?
5.11 IMPACT OF 2025 US TARIFFS ON CELL ISOLATION MARKET 85
5.11.1 INTRODUCTION 85
5.11.2 KEY TARIFF RATES 85
5.11.3 PRICE IMPACT ANALYSIS 86
5.11.4 IMPACT ON COUNTRY/REGION 87
5.11.4.1 US 87
5.11.4.2 Europe 87
5.11.4.3 Asia Pacific 88
5.11.5 IMPACT ON END-USE INDUSTRIES 88
5.11.5.1 Pharmaceutical & biotechnology companies 88
5.11.5.2 Academic & research institutes 88
5.11.5.3 Hospitals & diagnostic laboratories 89
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 90
6.1 TECHNOLOGY ANALYSIS 90
6.1.1 KEY TECHNOLOGIES 90
6.1.1.1 Centrifugation-based techniques 90
6.1.1.2 Magnetic cell isolation 90
6.1.1.3 Fluorescence-activated cell sorting 91
6.1.1.4 Acoustofluidic cell isolation 91
6.1.1.5 Filtration & size-based cell isolation 91
6.1.2 COMPLEMENTARY TECHNOLOGIES 92
6.1.2.1 Mass cytometry 92
6.1.2.2 Cell imaging technologies 92
6.1.2.3 AI-enabled image-based sorting 92
6.1.3 ADJACENT TECHNOLOGIES 93
6.1.3.1 Single-cell sequencing 93
6.1.3.2 CRISPR & gene editing 93
6.1.3.3 3D cell culture & organoids 93
6.2 TECHNOLOGY ROADMAP 94
6.3 PATENT ANALYSIS 94
6.3.1 METHODOLOGY 94
6.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 94
6.3.3 LIST OF KEY PATENTS 95
6.4 FUTURE APPLICATIONS 96
6.5 IMPACT OF AI/GEN AI ON CELL ISOLATION MARKET 97
6.5.1 TOP USE CASES & MARKET POTENTIAL 98
6.5.2 BEST PRACTICES IN AI-ENABLED CELL ISOLATION WORKFLOWS 99
6.5.3 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET 99
6.5.4 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS 99
6.5.5 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES 100
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 102
7.1 DECISION-MAKING PROCESS 102
7.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 102
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
7.2.2 KEY BUYING CRITERIA, BY END USER 103
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 104
7.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 105
8 SUSTAINABILITY & REGULATORY LANDSCAPE 106
8.1 REGIONAL REGULATIONS & COMPLIANCE 106
8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
8.1.2 INDUSTRY STANDARDS 108
8.1.2.1 North America 109
8.1.2.2 Europe 109
8.1.2.3 Asia Pacific 110
8.1.2.4 Rest of the world 110
8.2 SUSTAINABILITY INITIATIVES 111
8.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 111
8.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 112
9 CELL ISOLATION MARKET, BY PRODUCT 115
9.1 INTRODUCTION 116
9.2 CONSUMABLES 116
9.2.1 REAGENTS & KITS 120
9.2.1.1 Cell isolation reagents & kits 124
9.2.1.1.1 Expansion of downstream single-cell genomics to drive market 124
9.2.1.2 Tissue dissociation reagents & kits 127
9.2.1.2.1 Influx of solid tumor oncology profiling and primary cell culture derivations to drive growth 127
9.2.1.3 Other reagents & kits 131
9.2.2 MEDIA & SERA 134
9.2.2.1 Rising focus on viable, reproducible, and clinically compatible isolated cell workflows to fuel market 134
9.2.3 BEADS 137
9.2.3.1 Growing demand for beads in T-cell and stem cell isolation to drive market growth 137
9.2.4 DISPOSABLES 141
9.2.4.1 Growing government investments in research to aid market growth 141
?
9.3 INSTRUMENTS 144
9.3.1 CENTRIFUGES 148
9.3.1.1 Growing use in pharma-biotech industry to boost market 148
9.3.2 CELL SORTERS 152
9.3.2.1 Rise in cell-based research initiatives to augment growth 152
9.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 155
9.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market 155
9.3.4 FILTRATION SYSTEMS 159
9.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market 159
9.3.5 OTHER INSTRUMENTS 163
10 CELL ISOLATION MARKET, BY CELL TYPE 166
10.1 INTRODUCTION 167
10.2 HUMAN CELLS 167
10.2.1 DIFFERENTIATED CELLS 171
10.2.1.1 Rising use of mature human cell populations in translational research and drug development to fuel growth 171
10.2.2 STEM CELLS 174
10.2.2.1 Rise in grants and funding for stem cell research to drive market 174
10.3 ANIMAL CELLS 178
10.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH 178
11 CELL ISOLATION MARKET, BY CELL SOURCE 182
11.1 INTRODUCTION 183
11.2 BLOOD & BLOOD-DERIVED SAMPLES 183
11.2.1 GROWING USE OF IMMUNE CELL ISOLATION FROM BLOOD-DERIVED SAMPLES TO DRIVE MARKET 183
11.3 ADIPOSE TISSUE 187
11.3.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET 187
11.4 BONE MARROW 190
11.4.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH 190
11.5 CORD BLOOD/EMBRYONIC STEM CELLS 194
11.5.1 GROWING USE OF STEM AND PROGENITOR CELL ISOLATION IN REGENERATIVE MEDICINE AND CELL THERAPY RESEARCH TO SUPPORT MARKET GROWTH 194
11.6 OTHER CELL SOURCES 197
?
12 CELL ISOLATION MARKET, BY TECHNIQUE 201
12.1 INTRODUCTION 202
12.2 CENTRIFUGATION-BASED CELL ISOLATION 202
12.2.1 RISING DEMAND FOR SCALABLE, AUTOMATED, AND CLOSED CELL PREPARATION WORKFLOWS TO FUEL MARKET 202
12.3 SURFACE MARKER-BASED CELL ISOLATION 206
12.3.1 GROWING NEED FOR MARKER-SPECIFIC AND HIGH-PURITY CELL POPULATIONS TO PROPEL MARKET 206
12.4 FILTRATION-BASED CELL ISOLATION 209
12.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET 209
12.5 MICROFLUIDICS & LABEL-FREE CELL ISOLATION 213
12.5.1 HIGH DEMAND FOR ONCOLOGY RESEARCH TO SUPPORT SEGMENTAL GROWTH 213
13 CELL ISOLATION MARKET, BY APPLICATION 216
13.1 INTRODUCTION 217
13.2 RESEARCH APPLICATIONS 217
13.2.1 BIOMOLECULE ISOLATION 221
13.2.1.1 Increasing demand for biopharmaceutical products to fuel market 221
13.2.2 CANCER RESEARCH 225
13.2.2.1 Precision oncology and rare tumor cell analysis to drive market 225
13.2.3 STEM CELL RESEARCH 228
13.2.3.1 Rising grants and funding for stem cell research to augment growth 228
13.2.4 REGENERATIVE MEDICINE 232
13.2.4.1 Expanding stem cell and translational therapy research to support market 232
13.2.5 OTHER RESEARCH APPLICATIONS 235
13.3 DRUG DISCOVERY & DEVELOPMENT 239
13.3.1 RISING ADOPTION OF CELL-BASED DRUG DISCOVERY AND PRECISION THERAPEUTICS TO PROPEL MARKET 239
13.4 IN VITRO DIAGNOSTICS 242
13.4.1 RISING ADOPTION OF LIQUID BIOPSY AND PRECISION DIAGNOSTICS TO PROPEL MARKET 242
13.5 CGT MANUFACTURING 246
13.5.1 EXPANSION OF GMP-COMPLIANT CGT MANUFACTURING CAPACITY TO PROPEL MARKET 246
?
14 CELL ISOLATION MARKET, BY END USER 250
14.1 INTRODUCTION 251
14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 251
14.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH 251
14.3 ACADEMIC & RESEARCH INSTITUTES 255
14.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT 255
14.4 HOSPITALS & DIAGNOSTIC LABORATORIES 258
14.4.1 RISING DEMAND FOR ENRICHED CLINICAL CELL POPULATIONS IN ONCOLOGY AND HEMATOLOGY DIAGNOSTICS TO DRIVE MARKET 258
14.5 OTHER END USERS 262
15 CELL ISOLATION MARKET, BY REGION 265
15.1 INTRODUCTION 266
15.2 NORTH AMERICA 266
15.2.1 US 272
15.2.1.1 Strong biopharma R&D and advanced cell sorting adoption to drive market 272
15.2.2 CANADA 276
15.2.2.1 Expanding cell therapy manufacturing and regenerative medicine research to propel market 276
15.3 EUROPE 281
15.3.1 GERMANY 286
15.3.1.1 Strong cell & gene therapy translation and GMP-ready automated cell processing to aid market growth 286
15.3.2 UK 291
15.3.2.1 Expanding advanced therapy infrastructure and GMP-compatible cell processing workflows to drive market 291
15.3.3 FRANCE 296
15.3.3.1 Expanding biotherapy research and cell & gene therapy infrastructure to drive market 296
15.3.4 ITALY 301
15.3.4.1 Expanding advanced therapy trials and ex vivo gene therapy capabilities to drive market 301
15.3.5 SPAIN 306
15.3.5.1 Hospital-based CAR-T manufacturing and GMP-compatible cell processing workflows to aid growth 306
15.3.6 REST OF EUROPE 311
?
15.4 ASIA PACIFIC 316
15.4.1 CHINA 322
15.4.1.1 Expanding cell therapy pipelines and regenerative medicine commercialization to boost market 322
15.4.2 JAPAN 327
15.4.2.1 iPSC research leadership, regenerative medicine commercialization, and domestic cell therapy manufacturing expansion to drive market growth 327
15.4.3 INDIA 332
15.4.3.1 BioE3-led biomanufacturing and translational research expansion propel market 332
15.4.4 AUSTRALIA 337
15.4.4.1 Hospital-linked GMP cell therapy capacity, regenerative medicine trials, and translational research infrastructure to fuel market 337
15.4.5 SOUTH KOREA 342
15.4.5.1 Bioprocessing infrastructure expansion and regenerative medicine focus to support market growth 342
15.4.6 REST OF ASIA PACIFIC 347
15.5 LATIN AMERICA 352
15.5.1 BRAZIL 357
15.5.1.1 Advanced therapy regulation and oncology research strength to drive market 357
15.5.2 MEXICO 362
15.5.2.1 Regulatory strengthening and pharmaceutical infrastructure growth to support the market 362
15.5.3 REST OF LATIN AMERICA 367
15.6 MIDDLE EAST 372
15.6.1 GCC COUNTRIES 378
15.6.1.1 Saudi Arabia 383
15.6.1.1.1 Local advanced therapy manufacturing and precision medicine investment to boost market 383
15.6.1.2 UAE 388
15.6.1.2.1 Stem cell research infrastructure and regenerative medicine standards to aid market growth 388
15.6.1.3 Rest of GCC Countries 393
15.6.2 REST OF MIDDLE EAST 398
15.7 AFRICA 403
15.7.1 POPULATION-SPECIFIC ONCOLOGY RESEARCH AND INFECTIOUS DISEASE STUDIES TO PROPEL MARKET 403
?
16 COMPETITIVE LANDSCAPE 409
16.1 OVERVIEW 409
16.2 KEY PLAYER STRATEGY/RIGHT TO WIN, JANUARY 2023?APRIL 2026 409
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET, JANUARY 2023?APRIL 2026 409
16.3 REVENUE ANALYSIS, 2021?2025 411
16.4 MARKET SHARE ANALYSIS, 2025 412
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 414
16.5.1 STARS 414
16.5.2 EMERGING LEADERS 414
16.5.3 PERVASIVE PLAYERS 414
16.5.4 PARTICIPANTS 415
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 416
16.5.5.1 Company footprint 416
16.5.5.2 Region footprint 417
16.5.5.3 Product footprint 418
16.5.5.4 Cell type footprint 419
16.5.5.5 End-user footprint 420
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 421
16.6.1 PROGRESSIVE COMPANIES 421
16.6.2 RESPONSIVE COMPANIES 421
16.6.3 DYNAMIC COMPANIES 421
16.6.4 STARTING BLOCKS 421
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 423
16.6.5.1 Detailed list of key startup/SME players 423
16.6.5.2 Competitive benchmarking of startups/SMEs 424
16.7 COMPANY VALUATION & FINANCIAL METRICS 425
16.7.1 COMPANY VALUATION 425
16.7.2 FINANCIAL METRICS 425
16.8 BRAND/PRODUCT COMPARISON 426
16.9 COMPETITIVE SCENARIO 427
16.9.1 PRODUCT LAUNCHES 427
16.9.2 DEALS 428
16.9.3 EXPANSIONS 429
?
17 COMPANY PROFILES 430
17.1 KEY PLAYERS 430
17.1.1 DANAHER CORPORATION 430
17.1.1.1 Business overview 430
17.1.1.2 Products offered 431
17.1.1.3 Recent developments 432
17.1.1.3.1 Deals 432
17.1.1.4 MnM view 433
17.1.1.4.1 Key strengths 433
17.1.1.4.2 Strategic choices 433
17.1.1.4.3 Weaknesses & competitive threats 433
17.1.2 MERCK KGAA 434
17.1.2.1 Business overview 434
17.1.2.2 Products offered 435
17.1.2.3 Recent developments 436
17.1.2.3.1 Deals 436
17.1.2.3.2 Expansions 436
17.1.2.4 MnM view 437
17.1.2.4.1 Key strengths 437
17.1.2.4.2 Strategic choices 437
17.1.2.4.3 Weaknesses & competitive threats 437
17.1.3 THERMO FISHER SCIENTIFIC INC. 438
17.1.3.1 Business overview 438
17.1.3.2 Products offered 439
17.1.3.3 Recent developments 443
17.1.3.3.1 Product launches 443
17.1.3.3.2 Deals 444
17.1.3.3.3 Expansions 445
17.1.3.4 MnM view 446
17.1.3.4.1 Key strengths 446
17.1.3.4.2 Strategic choices 446
17.1.3.4.3 Weaknesses & competitive threats 446
17.1.4 BECTON, DICKINSON AND COMPANY 447
17.1.4.1 Business overview 447
17.1.4.2 Products offered 448
17.1.4.3 Recent developments 451
17.1.4.3.1 Product launches 451
17.1.4.3.2 Deals 451
17.1.4.4 MnM view 451
17.1.4.4.1 Key strengths 451
17.1.4.4.2 Strategic choices 452
17.1.4.4.3 Weaknesses & competitive threats 452
17.1.5 AGILENT TECHNOLOGIES, INC. 453
17.1.5.1 Business overview 453
17.1.5.2 Products offered 454
17.1.5.3 Recent developments 455
17.1.5.3.1 Deals 455
17.1.5.4 MnM view 455
17.1.5.4.1 Key strengths 455
17.1.5.4.2 Strategic choices 455
17.1.5.4.3 Weaknesses & competitive threats 455
17.1.6 SARTORIUS AG 456
17.1.6.1 Business overview 456
17.1.6.2 Products offered 457
17.1.7 BIO-RAD LABORATORIES, INC. 459
17.1.7.1 Business overview 459
17.1.7.2 Products offered 460
17.1.7.3 Recent developments 461
17.1.7.3.1 Product launches 461
17.1.8 QIAGEN 462
17.1.8.1 Business overview 462
17.1.8.2 Products offered 463
17.1.8.3 Recent developments 464
17.1.8.3.1 Deals 464
17.1.9 F. HOFFMANN-LA ROCHE LTD. 465
17.1.9.1 Business overview 465
17.1.9.2 Products offered 466
17.1.9.3 Recent developments 467
17.1.9.3.1 Expansions 467
17.1.10 REVVITY 468
17.1.10.1 Business overview 468
17.1.10.2 Products offered 469
17.1.11 CORNING INCORPORATED 472
17.1.11.1 Business overview 472
17.1.11.2 Products offered 473
17.1.12 LONZA 475
17.1.12.1 Business overview 475
17.1.12.2 Products offered 476
17.1.13 BIO-TECHNE 477
17.1.13.1 Business overview 477
17.1.13.2 Products offered 478
17.1.14 TERUMO CORPORATION 480
17.1.14.1 Business overview 480
17.1.14.2 Products offered 481
17.1.15 MILTENYI BIOTEC 482
17.1.15.1 Business overview 482
17.1.15.2 Products offered 482
17.1.16 TAKARA BIO INC. 484
17.1.16.1 Business overview 484
17.1.16.2 Products offered 485
17.1.17 GENSCRIPT 487
17.1.17.1 Business overview 487
17.1.17.2 Products offered 488
17.1.17.3 Recent developments 489
17.1.17.3.1 Deals 489
17.1.18 SONY CORPORATION 490
17.1.18.1 Business overview 490
17.1.18.2 Products offered 491
17.1.19 ALFA LAVAL 492
17.1.19.1 Business overview 492
17.1.19.2 Products offered 493
17.1.19.3 Recent developments 494
17.1.19.3.1 Product launches 494
17.1.19.3.2 Deals 495
17.2 OTHER PLAYERS 496
17.2.1 PROMEGA CORPORATION 496
17.2.2 CELL SIGNALING TECHNOLOGY, INC. 497
17.2.3 MICAREO INC. 497
17.2.4 APPLIED CELLS, INC. 498
17.2.5 STEMCELL TECHNOLOGIES 499
17.2.6 CREATIVE BIOARRAY 500
17.2.7 PROTEINTECH GROUP, INC. 500
17.2.8 MAGBIO GENOMICS, INC. 501
17.2.9 AKADEUM LIFE SCIENCES 502
17.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHR?NKT) & CO. KG 503
17.2.11 INVENT BIOTECHNOLOGIES, INC. 504
18 RESEARCH METHODOLOGY 505
18.1 RESEARCH DATA 505
18.1.1 SECONDARY DATA 505
18.1.1.1 Key data from secondary sources 505
18.1.2 PRIMARY DATA 506
18.1.2.1 Key data from primary sources 506
18.1.2.2 Key primary participants 506
18.1.2.3 Breakdown of primary interviews 507
18.1.2.4 Key industry insights 508
18.2 MARKET SIZE ESTIMATION 509
18.2.1 GLOBAL CELL ISOLATION MARKET ESTIMATION, 2025 509
18.2.2 SEGMENTAL MARKET SIZE ESTIMATION 511
18.3 MARKET GROWTH RATE PROJECTIONS 513
18.4 DATA TRIANGULATION 514
18.5 FACTOR ANALYSIS 515
18.6 RESEARCH ASSUMPTIONS 515
18.7 RESEARCH LIMITATIONS & RISK ASSESSMENT 516
19 APPENDIX 517
19.1 DISCUSSION GUIDE 517
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 521
19.3 CUSTOMIZATION OPTIONS 523
19.4 RELATED REPORTS 523
19.5 AUTHOR DETAILS 524

ページTOPに戻る

List of Tables/Graphs

TABLE 1 CELL ISOLATION MARKET: INCLUSIONS & EXCLUSIONS 48
TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 60
TABLE 3 CELL ISOLATION MARKET: PORTER’S FIVE FORCES 68
TABLE 4 CELL ISOLATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM 75
TABLE 5 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY TYPE, 2023?2025 (USD) 76
TABLE 6 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY TYPE, 2023?2025 (USD) 77
TABLE 7 AVERAGE SELLING PRICE TREND OF CELL ISOLATION INSTRUMENTS, BY REGION, 2023?2025 (USD) 78
TABLE 8 AVERAGE SELLING PRICE TREND OF CELL ISOLATION CONSUMABLES, BY REGION, 2023?2025 (USD) 78
TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 80
TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021?2025 (USD THOUSAND) 80
TABLE 11 CELL ISOLATION MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026?MARCH 2027 81
TABLE 12 RECIPROCAL TARIFF RATES ADJUSTED BY US 85
TABLE 13 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 87
TABLE 14 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015?2025 94
TABLE 15 LIST OF KEY PATENTS IN CELL ISOLATION MARKET, 2023?2025 95
TABLE 16 CASE STUDIES OF AI IMPLEMENTATION IN CELL ISOLATION MARKET 99
TABLE 17 CLIENTS’ READINESS TO ADOPT AI-INTEGRATED CELL ISOLATION TECHNOLOGIES IN CELL ISOLATION MARKET 100
TABLE 18 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 103
TABLE 19 KEY BUYING CRITERIA, BY END USER 103
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
TABLE 24 CELL ISOLATION MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 116
TABLE 25 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2024?2031 (USD MILLION) 117
TABLE 26 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 117
TABLE 27 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 118
TABLE 28 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 118
TABLE 29 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 119
TABLE 30 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET, BY REGION,
2024?2031 (USD MILLION) 119
TABLE 31 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 119
TABLE 32 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2024?2031 (USD MILLION) 120
TABLE 33 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024?2031 (USD MILLION) 121
TABLE 34 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024?2031 (USD MILLION) 121
TABLE 35 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS,
BY COUNTRY, 2024?2031 (USD MILLION) 122
TABLE 36 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024?2031 (USD MILLION) 122
TABLE 37 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024?2031 (USD MILLION) 123
TABLE 38 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY REGION, 2024?2031 (USD MILLION) 123
TABLE 39 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY COUNTRY, 2024?2031 (USD MILLION) 123
TABLE 40 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS & KITS, BY TYPE, 2024?2031 (USD MILLION) 124
TABLE 41 CELL ISOLATION REAGENTS & KITS MARKET, BY REGION,
2024?2031 (USD MILLION) 124
TABLE 42 NORTH AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 125
TABLE 43 EUROPE: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 125
TABLE 44 ASIA PACIFIC: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 126
TABLE 45 LATIN AMERICA: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 126
TABLE 46 MIDDLE EAST: CELL ISOLATION REAGENTS & KITS MARKET, BY REGION,
2024?2031 (USD MILLION) 127
TABLE 47 GCC COUNTRIES: CELL ISOLATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 127
TABLE 48 TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION,
2024?2031 (USD MILLION) 128
TABLE 49 NORTH AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 128
TABLE 50 EUROPE: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 129
TABLE 51 ASIA PACIFIC: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 129
TABLE 52 LATIN AMERICA: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 130
TABLE 53 MIDDLE EAST: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY REGION, 2024?2031 (USD MILLION) 130
TABLE 54 GCC COUNTRIES: TISSUE DISSOCIATION REAGENTS & KITS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 130
TABLE 55 OTHER REAGENTS & KITS MARKET, BY REGION, 2024?2031 (USD MILLION) 131
TABLE 56 NORTH AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 131
TABLE 57 EUROPE: OTHER REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 132
TABLE 58 ASIA PACIFIC: OTHER REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 132
TABLE 59 LATIN AMERICA: OTHER REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 133
TABLE 60 MIDDLE EAST: OTHER REAGENTS & KITS MARKET, BY REGION,
2024?2031 (USD MILLION) 133
TABLE 61 GCC COUNTRIES: OTHER REAGENTS & KITS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 133
TABLE 62 CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY REGION,
2024?2031 (USD MILLION) 134
TABLE 63 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024?2031 (USD MILLION) 135
TABLE 64 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA,
BY COUNTRY, 2024?2031 (USD MILLION) 135
TABLE 65 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA,
BY COUNTRY, 2024?2031 (USD MILLION) 136
TABLE 66 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA,
BY COUNTRY, 2024?2031 (USD MILLION) 136
TABLE 67 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA,
BY REGION, 2024?2031 (USD MILLION) 137
TABLE 68 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR MEDIA & SERA, BY COUNTRY, 2024?2031 (USD MILLION) 137
TABLE 69 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION,
2024?2031 (USD MILLION) 138
TABLE 70 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS,
BY COUNTRY, 2024?2031 (USD MILLION) 138
TABLE 71 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024?2031 (USD MILLION) 139
TABLE 72 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2024?2031 (USD MILLION) 139
TABLE 73 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS,
BY COUNTRY, 2024?2031 (USD MILLION) 140
TABLE 74 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2024?2031 (USD MILLION) 140
TABLE 75 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR BEADS,
BY COUNTRY, 2024?2031 (USD MILLION) 140
TABLE 76 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION,
2024?2031 (USD MILLION) 141
TABLE 77 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024?2031 (USD MILLION) 142
TABLE 78 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024?2031 (USD MILLION) 142
TABLE 79 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024?2031 (USD MILLION) 143
TABLE 80 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024?2031 (USD MILLION) 143
TABLE 81 MIDDLE EAST: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2024?2031 (USD MILLION) 144
TABLE 82 GCC COUNTRIES: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2024?2031 (USD MILLION) 144
TABLE 83 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024?2031 (USD MILLION) 145
TABLE 84 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 145
TABLE 85 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 146
TABLE 86 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 146
TABLE 87 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 147
TABLE 88 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET, BY REGION,
2024?2031 (USD MILLION) 147
TABLE 89 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 147
TABLE 90 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 148
TABLE 91 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION,
2024?2031 (USD MILLION) 149
TABLE 92 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY COUNTRY, 2024?2031 (USD MILLION) 149
TABLE 93 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY COUNTRY, 2024?2031 (USD MILLION) 150
TABLE 94 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY COUNTRY, 2024?2031 (USD MILLION) 150
TABLE 95 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY COUNTRY, 2024?2031 (USD MILLION) 151
TABLE 96 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY REGION, 2024?2031 (USD MILLION) 151
TABLE 97 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES,
BY COUNTRY, 2024?2031 (USD MILLION) 151
TABLE 98 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION,
2024?2031 (USD MILLION) 152
TABLE 99 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024?2031 (USD MILLION) 153
TABLE 100 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS,
BY COUNTRY, 2024?2031 (USD MILLION) 153
TABLE 101 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS,
BY COUNTRY, 2024?2031 (USD MILLION) 154
TABLE 102 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS,
BY COUNTRY, 2024?2031 (USD MILLION) 154
TABLE 103 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS,
BY REGION, 2024?2031 (USD MILLION) 155
TABLE 104 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2024?2031 (USD MILLION) 155
TABLE 105 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024?2031 (USD MILLION) 156
TABLE 106 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 156
TABLE 107 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 157
TABLE 108 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 157
TABLE 109 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 158
TABLE 110 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2024?2031 (USD MILLION) 158
TABLE 111 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 158
TABLE 112 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024?2031 (USD MILLION) 160
TABLE 113 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 160
TABLE 114 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS,
BY COUNTRY, 2024?2031 (USD MILLION) 161
TABLE 115 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 161
TABLE 116 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 162
TABLE 117 MIDDLE EAST: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2024?2031 (USD MILLION) 162
TABLE 118 GCC COUNTRIES: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2024?2031 (USD MILLION) 162
TABLE 119 OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION,
2024?2031 (USD MILLION) 163
TABLE 120 NORTH AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 163
TABLE 121 EUROPE: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 164
TABLE 122 ASIA PACIFIC: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 164
TABLE 123 LATIN AMERICA: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 165
TABLE 124 MIDDLE EAST: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2024?2031 (USD MILLION) 165
TABLE 125 GCC COUNTRIES: OTHER CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 165
TABLE 126 CELL ISOLATION MARKET, BY CELL TYPE, 2024?2031 (USD MILLION) 167
TABLE 127 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION,
2024?2031 (USD MILLION) 168
TABLE 128 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 168
TABLE 129 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 169
TABLE 130 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 169
TABLE 131 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 170
TABLE 132 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION,
2024?2031 (USD MILLION) 170
TABLE 133 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 170
TABLE 134 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,
2024?2031 (USD MILLION) 171
TABLE 135 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION,
2024?2031 (USD MILLION) 171
TABLE 136 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 137 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 138 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 173
TABLE 139 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 173
TABLE 140 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2024?2031 (USD MILLION) 174
TABLE 141 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 174
TABLE 142 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION,
2024?2031 (USD MILLION) 175
TABLE 143 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 175
TABLE 144 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 176
TABLE 145 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 176
TABLE 146 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 177
TABLE 147 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION,
2024?2031 (USD MILLION) 177
TABLE 148 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 177
TABLE 149 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION,
2024?2031 (USD MILLION) 178
TABLE 150 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 179
TABLE 151 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 179
TABLE 152 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY,
2024?2031 (USD MILLION) 180
TABLE 153 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 180
TABLE 154 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION,
2024?2031 (USD MILLION) 181
TABLE 155 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 181
TABLE 156 CELL ISOLATION MARKET, BY CELL SOURCE, 2024?2031 (USD MILLION) 183
TABLE 157 CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024?2031 (USD MILLION) 184
TABLE 158 NORTH AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024?2031 (USD MILLION) 184
TABLE 159 EUROPE: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES,
BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 160 ASIA PACIFIC: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 161 LATIN AMERICA: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024?2031 (USD MILLION) 186
TABLE 162 MIDDLE EAST: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY REGION, 2024?2031 (USD MILLION) 186
TABLE 163 GCC COUNTRIES: CELL ISOLATION MARKET FOR BLOOD & BLOOD-DERIVED SAMPLES, BY COUNTRY, 2024?2031 (USD MILLION) 186
TABLE 164 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION,
2024?2031 (USD MILLION) 187
TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024?2031 (USD MILLION) 188
TABLE 166 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY,
2024?2031 (USD MILLION) 188
TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024?2031 (USD MILLION) 189
TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024?2031 (USD MILLION) 189
TABLE 169 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2024?2031 (USD MILLION) 190
TABLE 170 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2024?2031 (USD MILLION) 190
TABLE 171 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION,
2024?2031 (USD MILLION) 191
TABLE 172 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024?2031 (USD MILLION) 191
TABLE 173 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY,
2024?2031 (USD MILLION) 192
TABLE 174 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024?2031 (USD MILLION) 192
TABLE 175 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024?2031 (USD MILLION) 193
TABLE 176 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION,
2024?2031 (USD MILLION) 193
TABLE 177 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2024?2031 (USD MILLION) 193
TABLE 178 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024?2031 (USD MILLION) 194
TABLE 179 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 180 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 195
TABLE 181 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS,
BY COUNTRY, 2024?2031 (USD MILLION) 196
TABLE 182 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 196
TABLE 183 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2024?2031 (USD MILLION) 197
TABLE 184 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2024?2031 (USD MILLION) 197
TABLE 185 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION,
2024?2031 (USD MILLION) 198
TABLE 186 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2024?2031 (USD MILLION) 198
TABLE 187 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024?2031 (USD MILLION) 199
TABLE 188 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2024?2031 (USD MILLION) 199
TABLE 189 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2024?2031 (USD MILLION) 200
TABLE 190 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2024?2031 (USD MILLION) 200
TABLE 191 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES,
BY COUNTRY, 2024?2031 (USD MILLION) 200
TABLE 192 CELL ISOLATION MARKET, BY TECHNIQUE, 2024?2031 (USD MILLION) 202
TABLE 193 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION,
2024?2031 (USD MILLION) 203
TABLE 194 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 203
TABLE 195 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 204
TABLE 196 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 204
TABLE 197 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 205
TABLE 198 MIDDLE EAST: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024?2031 (USD MILLION) 205
TABLE 199 GCC COUNTRIES: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2024?2031 (USD MILLION) 205
TABLE 200 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION,
2024?2031 (USD MILLION) 206
TABLE 201 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 207
TABLE 202 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 207
TABLE 203 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 208
TABLE 204 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 208
TABLE 205 MIDDLE EAST: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2024?2031 (USD MILLION) 209
TABLE 206 GCC COUNTRIES: SURFACE MARKER-BASED CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 209
TABLE 207 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION,
2024?2031 (USD MILLION) 210
TABLE 208 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 210
TABLE 209 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 211
TABLE 210 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 211
TABLE 211 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 212 MIDDLE EAST: FILTRATION-BASED CELL ISOLATION MARKET, BY REGION,
2024?2031 (USD MILLION) 212
TABLE 213 GCC COUNTRIES: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 214 MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY REGION,
2024?2031 (USD MILLION) 213
TABLE 215 NORTH AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 213
TABLE 216 EUROPE: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 214
TABLE 217 ASIA PACIFIC: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 214
TABLE 218 LATIN AMERICA: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 215
TABLE 219 MIDDLE EAST: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET,
BY REGION, 2024?2031 (USD MILLION) 215
TABLE 220 GCC COUNTRIES: MICROFLUIDICS & LABEL-FREE CELL ISOLATION MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 215
TABLE 221 CELL ISOLATION MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 217
TABLE 222 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2024?2031 (USD MILLION) 218
TABLE 223 NORTH AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 218
TABLE 224 EUROPE: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2024?2031 (USD MILLION) 219
TABLE 225 ASIA PACIFIC: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 219
TABLE 226 LATIN AMERICA: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 227 MIDDLE EAST: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2024?2031 (USD MILLION) 220
TABLE 228 GCC COUNTRIES: CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 220
TABLE 229 CELL ISOLATION MARKET FOR RESEARCH APPLICATIONS, BY TYPE,
2024?2031 (USD MILLION) 221
TABLE 230 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION,
2024?2031 (USD MILLION) 222
TABLE 231 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2024?2031 (USD MILLION) 222
TABLE 232 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2024?2031 (USD MILLION) 223
TABLE 233 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2024?2031 (USD MILLION) 223
TABLE 234 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2024?2031 (USD MILLION) 224
TABLE 235 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY REGION, 2024?2031 (USD MILLION) 224
TABLE 236 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION,
BY COUNTRY, 2024?2031 (USD MILLION) 224
TABLE 237 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION,
2024?2031 (USD MILLION) 225
TABLE 238 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2024?2031 (USD MILLION) 226
TABLE 239 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY,
2024?2031 (USD MILLION) 226
TABLE 240 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024?2031 (USD MILLION) 227
TABLE 241 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2024?2031 (USD MILLION) 227
TABLE 242 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2024?2031 (USD MILLION) 228
TABLE 243 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH,
BY COUNTRY, 2024?2031 (USD MILLION) 228
TABLE 244 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION,
2024?2031 (USD MILLION) 229
TABLE 245 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2024?2031 (USD MILLION) 229
TABLE 246 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 247 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 248 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2024?2031 (USD MILLION) 231
TABLE 249 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2024?2031 (USD MILLION) 231
TABLE 250 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH,
BY COUNTRY, 2024?2031 (USD MILLION) 231
TABLE 251 CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2024?2031 (USD MILLION) 232
TABLE 252 NORTH AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2024?2031 (USD MILLION) 233
TABLE 253 EUROPE: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2024?2031 (USD MILLION) 233
TABLE 254 ASIA PACIFIC: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 255 LATIN AMERICA: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 256 MIDDLE EAST: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE,
BY REGION, 2024?2031 (USD MILLION) 235
TABLE 257 GCC COUNTRIES: CELL ISOLATION MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2024?2031 (USD MILLION) 235
TABLE 258 CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 236
TABLE 259 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024?2031 (USD MILLION) 236
TABLE 260 EUROPE: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 237
TABLE 261 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 237
TABLE 262 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024?2031 (USD MILLION) 238
TABLE 263 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2024?2031 (USD MILLION) 238
TABLE 264 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2024?2031 (USD MILLION) 238
TABLE 265 CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024?2031 (USD MILLION) 239
TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024?2031 (USD MILLION) 240
TABLE 267 EUROPE: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2024?2031 (USD MILLION) 240
TABLE 268 ASIA PACIFIC: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024?2031 (USD MILLION) 241
TABLE 269 LATIN AMERICA: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024?2031 (USD MILLION) 241
TABLE 270 MIDDLE EAST: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024?2031 (USD MILLION) 242
TABLE 271 GCC COUNTRIES: CELL ISOLATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024?2031 (USD MILLION) 242
TABLE 272 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION,
2024?2031 (USD MILLION) 243
TABLE 273 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2024?2031 (USD MILLION) 243
TABLE 274 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024?2031 (USD MILLION) 244
TABLE 275 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2024?2031 (USD MILLION) 244
TABLE 276 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 277 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2024?2031 (USD MILLION) 245
TABLE 278 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS,
BY COUNTRY, 2024?2031 (USD MILLION) 245
TABLE 279 CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION,
2024?2031 (USD MILLION) 246
TABLE 280 NORTH AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING,
BY COUNTRY, 2024?2031 (USD MILLION) 247
TABLE 281 EUROPE: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024?2031 (USD MILLION) 247
TABLE 282 ASIA PACIFIC: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY COUNTRY, 2024?2031 (USD MILLION) 248
TABLE 283 LATIN AMERICA: CELL ISOLATION MARKET FOR CGT MANUFACTURING,
BY COUNTRY, 2024?2031 (USD MILLION) 248
TABLE 284 MIDDLE EAST: CELL ISOLATION MARKET FOR CGT MANUFACTURING, BY REGION, 2024?2031 (USD MILLION) 249
TABLE 285 GCC COUNTRIES: CELL ISOLATION MARKET FOR CGT MANUFACTURING,
BY COUNTRY, 2024?2031 (USD MILLION) 249
TABLE 286 CELL ISOLATION MARKET, BY END USER, 2024?2031 (USD MILLION) 251
TABLE 287 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 252
TABLE 288 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 252
TABLE 289 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 253
TABLE 290 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 253
TABLE 291 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 254
TABLE 292 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024?2031 (USD MILLION) 254
TABLE 293 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024?2031 (USD MILLION) 254
TABLE 294 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024?2031 (USD MILLION) 255
TABLE 295 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024?2031 (USD MILLION) 256
TABLE 296 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2024?2031 (USD MILLION) 256
TABLE 297 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024?2031 (USD MILLION) 257
TABLE 298 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024?2031 (USD MILLION) 257
TABLE 299 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024?2031 (USD MILLION) 258
TABLE 300 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024?2031 (USD MILLION) 258TABLE 301 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES,
BY REGION, 2024?2031 (USD MILLION) 259
TABLE 302 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 259
TABLE 303 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 260
TABLE 304 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 260
TABLE 305 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 261
TABLE 306 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2024?2031 (USD MILLION) 261
TABLE 307 GCC COUNTRIES: CELL ISOL